Cargando…
Richter Syndrome: From Molecular Pathogenesis to Druggable Targets
SIMPLE SUMMARY: Chronic lymphocytic leukemia represents the most frequent leukemia in adults and evolves from an indolent phase to an aggressive lymphoma in 5–10% of the cases. Such clinico-pathologic transformation is known as Richter syndrome and represents a major unmet medical need because of tr...
Autores principales: | Mouhssine, Samir, Gaidano, Gianluca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563287/ https://www.ncbi.nlm.nih.gov/pubmed/36230566 http://dx.doi.org/10.3390/cancers14194644 |
Ejemplares similares
-
Immunological Aspects of Richter Syndrome: From Immune Dysfunction to Immunotherapy
por: Mahmoud, Abdurraouf Mokhtar, et al.
Publicado: (2023) -
The involvement of microRNA in the pathogenesis of Richter syndrome
por: Van Roosbroeck, Katrien, et al.
Publicado: (2019) -
Clonally unrelated Richter syndrome are truly de novo diffuse large B‐cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome
por: Favini, Chiara, et al.
Publicado: (2022) -
Druggable Molecular Pathways in Chronic Lymphocytic Leukemia
por: Almasri, Mohammad, et al.
Publicado: (2022) -
Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers
por: Maher, Nawar, et al.
Publicado: (2023)